Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-05

Clinical Trial Update: A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers [NA]

View source ↗

Summary

A completed clinical trial evaluating whether immediate versus deferred lamivudine administration improves safe delivery of chemotherapy in patients with cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamivudine (lamivudine)

Snippet

Sponsor: Hospital Authority, Hong Kong | Conditions: Hepatitis B, Neoplasms | NA | Status: COMPLETED